 CLINICAL TRIAL III OPENED, RANDOMIZED AND CONTROLLED FOR THE STUDY OF THE USE OF STEM CELLS THERAPY IN INSULINIZED DIABETIC PATIENTS TYPE 2 WITH CRITICAL ISCHEMIA IN LOWER LIMBS CLI: STUDY OF THE NEEDS OF INSULIN: 